Document:

exv10w6

Exhibit 10.6

SLM CORPORATION

DIRECTORS EQUITY PLAN — NON-EMPLOYEE DIRECTOR STOCK OPTION AGREEMENT — 2009

          FOR GOOD AND VALUABLE CONSIDERATION, SLM Corporation, (the “Corporation”) hereby grants to
Optionee named below a non-qualified stock options (the “Options”) to purchase any part or all of
the number of shares of the Corporation’s $0.20 par value common stock (the “Common Stock”)
specified below, at the Exercise Price per share specified below and upon the terms and conditions
set forth in this agreement (“Agreement”) and the SLM Corporation Directors Equity Plan (the
“Plan”), each as may be amended from time to time. In the event of any conflict between the
provisions of this Agreement and the provisions of the Plan, the terms of the Plan shall control,
except as expressly stated otherwise herein.

	 	 	 
	Name of Optionee:

	 	«Name»
	 
	 	 
	Grant Date:

	 	May                    , 2009
	 
	 	 
	Number of Shares covered by Option:

	 	                    
	 
	 	 
	Exercise Price Per Share:

	 	                    
	 
	 	 
	Expiration Date:

	 	May                     , 2019
	 
	 	 
	Vesting:

	 	The Options are not vested as of the
Grant Date. All Options vest upon the
earlier of: (1) the Corporation’s
common stock price reaching a closing
price equal to or greater than                     
per share for five days, (2) five
years from the Grant Date, or (3) upon
termination of service from the Board
of Directors of the Corporation or any
of its subsidiaries for any reason,
unless the Options are terminated
earlier in accordance with the
provisions of the Plan or this
Agreement.
	 
	 	 
	Exercise Right Upon Termination:

	 	Vested Options
must be exercised within three years
after the date Optionee ceases to be a
member of the Board of Directors of
the Corporation or the Expiration
Date, whichever occurs first.

	1.	 	Definitions. Capitalized terms used herein are defined in the Plan or herein.
	 
	2.	 	Vesting Upon Change In Control. Notwithstanding anything to the contrary in this
Agreement, in the event of a Change of Control or a Change of Control Transaction, all Options
subject to this Agreement that were not previously exercisable shall become immediately
exercisable. In addition, if upon the announcement of a Change of Control Transaction, no
provision is made for the exercise, payment or lapse of conditions or restrictions on the
Award, or other procedure whereby the Optionee may realize the full benefit of the Award, then
all Options granted hereunder that were not previously vested and exercisable, shall
immediately become vested and exercisable.
	 
	3.	 	Transferability. These Options may not be transferred except as provided herein.
All or any part of these Options may be transferred by Optionee by will or by the laws of
descent and distribution. In addition, Optionee may transfer all or any part of any Option to
“Immediate Family Members” pursuant to a gift (a transfer that is not for value) or a domestic
relations order, as defined in the General Instructions to Form S-8 under the Securities Act
of 1933. “Immediate Family Members” means children, grandchildren, spouse or common law
spouse, siblings or parents of the Optionee or bona fide trusts, partnerships or other
entities controlled by and of which all beneficiaries are Immediate Family Members of the
Optionee. Any Options that are transferred are further conditioned on the Optionee and the
Optionee’s transferees and Immediate Family Members agreeing to abide by the Corporation’s
then current stock option transfer guidelines.
	 
	4.	 	Exercise of the Option. These Options shall be exercised only in accordance with the
terms of the Plan and this Agreement. Each exercise shall be for no fewer than fifty (50) shares, other than an exercise for all remaining Option shares. Upon exercise of all or part
of these Options, the Optionee shall pay the Option Price to the Corporation only in the
following manner: either (i) by cash or certified or cashier’s check, (ii) by arrangement with
a broker where payment is made pursuant to an irrevocable direction to the broker to sell
sufficient Option shares and pay the entire Option Price to the Corporation in cash, or (iii)
by delivery of shares of Common Stock of the Corporation. The value of any such shares
delivered as payment of the Option Price shall be such shares’ fair market value as indicated
by the price per share of the Corporation’s common stock at the time of exercise. In addition to the exercise methods
specified above, the Optionee may exercise Options using a net-settled method under which
the Optionee shall receive from the Corporation as a result of any Option exercise the
number of shares of common stock resulting from the following formula: the total number of
Options exercised less “shares for the option cost”. “Shares for the option cost” equals
the option exercise price multiplied by the number of options exercised divided by the Fair
Market Value of common stock at the time of exercise, rounded up to the nearest whole share.
The Corporation shall pay the option holder in cash the amount, if any, by which the Fair
Market Value of the “shares for the option cost” exceeds the option exercise price
multiplied by the number of options exercised.
	 
	5.	 	Notices. All notices, requests, demands and other communications under this
Agreement shall be in writing and shall be deemed to have been duly given if personally
delivered, telefaxed or telecopied to, or, if mailed, when received by, the other party at the
following addresses:

If to the Corporation to:

Carol R. Rakatansky

Vice President & Corporate Secretary

Page 1 of 3

 

SLM CORPORATION

DIRECTORS EQUITY PLAN — NON-EMPLOYEE DIRECTOR STOCK OPTION AGREEMENT — 2009

 SLM Corporation

 12061 Bluemont Way

 Reston, VA 20190

 Fax: 703-984-6006

	 	 	If to the Optionee, to the address listed on record.
	 
	6.	 	Board Interpretation. The Optionee hereby agrees to accept as binding, conclusive,
and final all decisions and interpretations of the Board and, where applicable, the Committee,
concerning any questions arising under this Agreement or the Plan.
	 
	7.	 	Amendments for Accounting Charges: The Committee reserves the right to unilaterally
amend this Agreement to reflect any changes in applicable law or financial accounting
standards.
	 
	8.	 	Securities Law Compliance; Restrictions on Resale’s of Option Shares. The
Corporation may impose such restrictions, conditions or limitations as it determines
appropriate as to the timing and manner of any exercise of these Options and/or any resales by
the Optionee or other subsequent transfers by the Optionee of any shares of Common Stock
issued as a result of the exercise of the Options, including without limitation (a)
restrictions under an insider trading policy, (b) restrictions that may be necessary in the
absence of an effective registration statement under the Securities Act of 1933, as amended,
covering the Options and/or the Common Stock underlying the Options and (c) restrictions as to
the use of a specified brokerage firm or other agent for exercising the Options and/or for
such resales or other transfers. The sale of the shares underlying the Options must also
comply with other applicable laws and regulations governing the sale of such shares.
	 
	9.	 	Data Privacy. As an essential term of this Option, the Optionee consents to the
collection, use and transfer, in electronic or other form, of personal data as described in
this Agreement for the exclusive purpose of implementing, administering and managing
Optionee’s participation in the Plan. By entering into this Agreement and accepting the
Option, the Optionee acknowledges that the Corporation holds certain personal information
about the Optionee, including, but not limited to, name, home address and telephone number,
date of birth, social security number or other identification number, salary, tax rates and
amounts, nationality, job title, any shares of stock held in the Corporation, details of all
options or any other entitlement to shares of stock awarded, canceled, exercised, vested,
unvested or outstanding, for the purpose of implementing, administering and managing the Plan
(“Data”). Optionee acknowledges that Data may be transferred to any third parties assisting
in the implementation, administration and management of the Plan, that these recipients may be
located in jurisdictions that may have different data privacy laws and protections, and
Optionee authorizes the recipients to receive, possess, use, retain and transfer the Data, in
electronic or other form, for the purposes of implementing, administering and managing the
Plan, including any requisite transfer of such Data as may be required to a broker or other
third party with whom the Optionee or the Corporation may elect to deposit any shares of
Common Stock acquired upon exercise of the Option. Optionee acknowledges that Data may be
held only as long as is necessary to implement, administer and manage the Optionee’s
participation in the Plan as determined by the Corporation, and that Optionee may request
additional information about the storage and processing of Data, require any necessary
amendments to Data or refuse or withdraw the consents herein, in any case without cost,
provided however, that refusing or withdrawing Optionee’s consent may adversely affect
Optionee’s ability to participate in the Plan.
	 
	10.	 	Electronic Delivery. The Corporation may, in its sole discretion, decide to deliver
any documents related to any options granted under the Plan by electronic means or to request
Optionee’s consent to participate in the Plan by electronic means. Optionee hereby consents to
receive such documents by electronic delivery and, if requested, to agree to participate in
the Plan through an on-line or electronic system established and maintained by the Corporation
or another third party designated by the Corporation, and such consent shall remain in effect
throughout Optionee’s term of service with the Corporation and thereafter until withdrawn in
writing by Optionee.
	 
	11.	 	Stockholder Rights. The Optionee shall not be deemed a stockholder of the
Corporation with respect to any of the shares of Common Stock subject to the Options, except
to the extent that such shares shall have been purchased and
transferred to the Optionee. The Corporation shall not be required to issue or transfer any
shares of Common Stock purchased upon exercise of the Options until all applicable
requirements of law have been complied with and such shares shall have been duly listed on
any securities exchange on which the Common Stock may then be listed.
	 
	12.	 	Miscellaneous. In the event that any provision of this Agreement is declared to be
illegal, invalid or otherwise unenforceable by a court of competent jurisdiction, such
provision shall be reformed, if possible, to the extent necessary to render it legal, valid
and enforceable, or otherwise deleted, and the remainder of this Agreement shall not be
affected except to the extent necessary to reform or delete such illegal, invalid or
unenforceable provision. The headings in this Agreement are solely for convenience of
reference, and shall not constitute a part of this Agreement, nor shall they affect its
meaning, construction or effect. The Optionee shall cooperate and take such actions as may be
reasonably requested by the Corporation in order to carry out the provisions and purposes of
the Agreement. The Optionee is responsible for complying with all laws applicable to
Optionee, including federal and state securities reporting laws.

        By accepting this Agreement, Optionee acknowledges that he or she has received and read, and
agrees that these Options shall be subject to this Agreement and the Plan. At any time, copies of
the Plan may be obtained by contacting Carol Rakatansky at (703) 984-5405.

	 	 	 	 	 
	 
	 	 	 	 
	 

	 	 

Signature:          «Name»
	 	 

Page 2 of 3

 

SLM CORPORATION

DIRECTORS EQUITY PLAN — NON-EMPLOYEE DIRECTOR STOCK OPTION AGREEMENT — 2009

	 	 	 	 	 
	 
	 	 	 	 
	 

	 	 

Date Signed:
	 	 

	 	 	 	 	 
	SLM CORPORATION	 	 
	 
	 	 	 	 
	
	 	 
	 
	BY:

	 	 

Albert L. Lord
	 	 
	 

	 	Chief Executive Officer	 	 

Page 3 of 3exv10w1

Exhibit 10.1

CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A
REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION.

AMENDMENT NO. 1 TO OTC LICENSE AGREEMENT

     This Amendment No. 1 (the “Amendment”) to the OTC License Agreement dated October 17, 2006
(the “License”), between Schering-Plough Healthcare Products, Inc. (“Schering”) and Santarus, Inc.
(“Santarus”) is made as of July 24, 2009 (the “Effective Date”).

RECITALS

     WHEREAS, Marketing Approval for the first Licensed Product has not yet been received; and

     WHEREAS, as a result, Schering may launch the first Licensed Product on a date that is later
than the date set forth in the diligence provisions of the License; and

     WHEREAS, Schering and Santarus desire to amend certain terms of the License to account for
those circumstances, as set forth herein.

     NOW, THEREFORE, for and in consideration of the covenants, conditions, and undertakings
hereinafter set forth, the Parties agree as follows:

AGREEMENT

     1. Amendment of Section 3.3.3. Section 3.3.3 of the License is hereby amended by
adding to the end, “Notwithstanding the foregoing, it is agreed that, should Schering receive
Marketing Approval for its first Licensed Product [***], then, for purposes of this Section 3.3.3,
the twelve month period for measuring Marketing Commitment shall be deemed to commence on [***].”

     2. Amendment of Section 3.7.2 (Diligence Milestone 4). Diligence Milestone 4 set
forth in Section 3.7.2 of the License is hereby amended by restating it in its entirety as follows:

	 	 	 	 	 
	“4.

	 	First Commercial Sale of the first Licensed Product in the   
	 	by [***]”
	 

	 	Territory	 	 

     3. Amendment of Section 3.7.3(a). Section 3.7.3(a) of the License is hereby amended
by adding to the beginning of the second sentence, “Except as provided in Section 3.7.3(c),”.

     4. Amendment of Section 3.7.3. Section 3.7.3 of the License is hereby amended by
adding a new subsection (c) as follows:

     “(c) Failure to Achieve First Commercial Sale. In the event that Schering fails to achieve
First Commercial Sale of the first Licensed Product in the Territory by [***] (if Marketing
Approval is received on or before [***]) or within [***] after receipt of Marketing Approval (if
Marketing Approval is received on or after [***]), then Schering shall pay to

 

			
	***	 	Certain information on this page has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

1

 

Santarus a fee of [***] (US$[***]) within thirty (30) days thereafter, which amount shall be
non-refundable and non-creditable against other amounts due to Santarus. Provided that Schering
has made the payment specified in this Section 3.7.3(c), Schering shall have a sixty (60) day cure
period with respect to failure to achieve Diligence Milestone 4 by the specified date, after which
Santarus shall have the right to terminate this Agreement in accordance with Section 3.7.3(a).”

     5. Amendment of Section 5.2 (Milestone Payments). Milestone 4 set forth in Section
5.2 of the License is hereby amended by restating it in its entirety as follows:

	 	 	 	 	 
	“4.

	 	First time in which either (a) Net Sales of Licensed
	 	US$[***]”
	 

	 	Products in the Territory reach or exceed US$[***], as measured	 	 
	 

	 	beginning on the date of First Commercial Sale and ending on the	 	 
	 

	 	first anniversary of that date, or (b) annual Net Sales of	 	 
	 

	 	Licensed Products in the Territory reach or exceed at least	 	 
	 

	 	US$[***].	 	 

     6. Amendment of Section 5.2 (Proviso 7). Proviso 7 set forth in Section 5.2 of the
License is hereby amended by restating it in its entirety as follows:

     “(7) Annual Net Sales for Milestones 4(b) through 7 shall be measured on a calendar year
basis; provided, however, that, if the Annual Net Sales amounts set forth for each of Milestones
4(b) through 7 are achieved prior to the fourth calendar quarter of the applicable calendar year,
then the corresponding milestone amounts shall be due following the applicable calendar quarter in
which such Annual Net Sales are achieved. For purposes of example only, in the event that the
annual Net Sales exceed $[***] for the first time during the third calendar quarter of a given
calendar year, the corresponding milestone amount of $[***] would be due following the end of such
calendar quarter. The Net Sales amount for Milestone 4(a) only shall be measured during the twelve
(12) month period beginning on the date of First Commercial Sale by Schering in the Territory;
provided, however, that, if the Net Sales amount set forth for Milestone 4(a) is achieved prior to
the end of the twelve (12) month period, then the milestone amount shall be due following the
applicable month in which such Net Sales are achieved. Payments for Milestones 4(b) through 7
shall be made thirty (30) days following the end of the applicable calendar quarter in which such
Annual Net Sales are achieved and payment for Milestone 4(a) shall be made thirty (30) days
following the end of the applicable month in which such Net Sales are achieved. It is understood
that Santarus is not entitled to payment under both Milestones 4(a) and 4(b).”

     7. Miscellaneous.

          a. Except for the amendments set forth herein, all other terms and conditions of the License
shall remain in full force and effect.

          b. This Amendment, and the License as amended by this Amendment, constitutes the entire
agreement between the Parties with respect to its subject matter and supersedes all previous
agreements, whether written or oral.

 

			
	***	 	Certain information on this page has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

2

 

          c. Capitalized terms used but not otherwise defined herein shall have the meanings
assigned to them in the License.

          d. The validity, performance, construction and effect of this Amendment shall be governed by
the laws of the State of New York, United States of America, without regard to conflicts of law
principles.

     IN WITNESS WHEREOF, the Parties have duly executed this Amendment as of the Effective Date.

SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC.

	 	 	 	 	 
	By: 
	 /s/ Nancy Miller - Rich	 	 
	 

	 	 

	 	 
	 	Name: 
	Nancy Miller - Rich	 	 
	 

	 	 

	 	 
	 	Title:
	GVP New Ventures & Strategic Commercial Development	 	 
	 

	 	 

	 	 

SANTARUS, INC.

	 	 	 	 	 
	By:  	       /s/ Gerald T. Proehl
 	 
	 
	 	Name:  	Gerald T. Proehl 	 
	 
	 	Title:  	President and CEO 	 
	 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00164-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00164-of-00352.parquet"}]]